AUTONOMIX MEDICAL, INC. Operating Cash Flow
AUTONOMIX MEDICAL, INC. (AMIX) reported Operating Cash Flow of -$3.54 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- AUTONOMIX MEDICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$3.54M.
- AUTONOMIX MEDICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.89M.
- AUTONOMIX MEDICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$2.97M.
- AUTONOMIX MEDICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.82M.
- AUTONOMIX MEDICAL, INC. net cash provided by (used in) operating activities for fiscal 2026 was -$12.28M.
- AUTONOMIX MEDICAL, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$8.26M.
- AUTONOMIX MEDICAL, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$6.60M.
- AUTONOMIX MEDICAL, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$1.85M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$3.54M 10-Q · filed 2026-08-13 | -$6.44M derived: sum of 2 quarters · filed 2026-08-13 | -$9.40M derived: sum of 3 quarters · filed 2026-08-13 | -$13.22M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | -$2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-27 | -$5.86M derived: sum of 2 quarters · filed 2026-05-27 | -$9.68M derived: sum of 3 quarters · filed 2026-05-27 | -$12.28M 10-K · filed 2026-05-27 | |
| 2025-12-31 | -$2.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11 | -$6.79M derived: sum of 2 quarters · filed 2026-02-11 | -$9.39M 10-Q · filed 2026-02-11 | -$17.65M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-09-30 | -$3.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-12 | -$6.42M 10-Q · filed 2025-11-12 | -$14.68M derived: sum of 3 quarters · filed 2026-08-13 | -$16.98M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | -$2.60M 10-Q · filed 2026-08-13 | -$10.86M derived: sum of 2 quarters · filed 2026-08-13 | -$13.16M derived: sum of 3 quarters · filed 2026-08-13 | -$14.76M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | -$8.26M 10-K · filed 2025-05-29 | -$10.56M derived: sum of 2 quarters · filed 2026-02-11 | -$12.15M derived: sum of 3 quarters · filed 2026-02-11 | -$8.26M 10-K · filed 2026-05-27 | -$8.30M 10-K · filed 2025-05-29 |
| 2024-12-31 | -$2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11 | -$3.90M derived: sum of 2 quarters · filed 2026-02-11 | -$5.75M 10-Q · filed 2026-02-11 | -$12.40M derived: sum of 4 quarters · filed 2026-02-11 | |
| 2024-09-30 | -$1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-12 | -$3.45M 10-Q · filed 2025-11-12 | -$10.10M derived: sum of 3 quarters · filed 2025-11-12 | -$12.65M derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | -$1.85M 10-Q · filed 2025-08-13 | -$8.50M derived: sum of 2 quarters · filed 2025-08-13 | -$11.06M derived: sum of 3 quarters · filed 2025-08-13 | -$12.20M derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | -$6.65M 10-K · filed 2025-05-29 | -$9.20M derived: sum of 2 quarters · filed 2025-05-29 | -$10.35M derived: sum of 3 quarters · filed 2025-05-29 | -$6.60M 10-K · filed 2025-05-29 | -$6.65M 10-K · filed 2024-05-31 |
| 2023-12-31 | -$2.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | -$3.70M derived: sum of 2 quarters · filed 2025-02-13 | -$4.36M 10-Q · filed 2025-02-13 | -$4.98M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-09-30 | -$1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-08 | -$1.80M 10-Q · filed 2024-11-08 | -$2.42M derived: sum of 3 quarters · filed 2024-11-08 | ||
| 2023-06-30 | -$661.00K 10-Q · filed 2024-08-13 | -$1.28M derived: sum of 2 quarters · filed 2024-08-13 | |||
| 2023-03-31 | -$620.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-31 | -$1.85M 10-K · filed 2024-05-31 | |||
| 2022-12-31 | -$1.23M 10-Q · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |